Sign In
Buy AEZS
$5.72
+0 (+0%)
At Close: Nov 13, 2024
Aeterna Zentaris Announces Results of 2021 Annual Meeting of Shareholders
04:35pm, Wednesday, 05'th May 2021
CHARLESTON, S.C., May 05, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercia
Aeterna Zentaris Reports First Quarter 2021 Financial Results and Provides Pipeline Program Updates
08:05am, Wednesday, 05'th May 2021
– Q1 2021 marked by solid operational execution with expansion and diversification of pipeline , intellectual property and portfolio of assets
Aeterna Zentaris Appoints Michael Teifel, Ph.D. as Senior Vice President, Non-Clinical Development and Chief Scientific Officer
08:05am, Monday, 03'rd May 2021
– Over 20 years of industry experience in translating research into clinical development in a wide range of therapeutic areas of endocrinology and oncology
Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders
08:05am, Wednesday, 28'th Apr 2021
CHARLESTON, S.C., April 28, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and de
3 Penny Stocks to Watch During the Last Week of April
09:33am, Monday, 26'th Apr 2021
As April comes to an end, are these 3 penny stocks worth watching? The post 3 Penny Stocks to Watch During the Last Week of April appeared first on Penny Stocks to Buy, Picks, News and Information | P
Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results
08:05am, Thursday, 25'th Mar 2021
– Company executing on growth strategy to build-out pipeline of development assets
Aeterna Zentaris Regains Compliance with Nasdaq Minimum Bid Price Requirement
04:05pm, Monday, 22'nd Mar 2021
CHARLESTON, S.C., March 22, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and de
AEZS Stock: Why Aeterna Zentaris Shares Are Shooting Higher Today
02:10pm, Monday, 15'th Mar 2021
Investors in AEZS stock have continued to pile into this trade today, with the stock up more than 40% on news around its Covid-19 vaccine. The post AEZS Stock: Why Aeterna Zentaris Shares Are Shooting
AEZS Stock Price Increases Over 10% Pre-Market: Why It Happened
08:53am, Monday, 15'th Mar 2021
The stock price of AEterna Zentaris Inc. (NASDAQ: AEZS) increased by over 10% pre-market. This is why it happened.
- Company secures next step to continue to build-out pipeline of assets
If You Like Long Shots, Aeterna Zentaris Stock Is Worth a Gamble
04:44pm, Thursday, 11'th Mar 2021
AEZS stock isn't something to bet your entire portfolio on, but since the company's a Covid-19 vaccine contender, it might be worth owning. The post If You Like Long Shots, Aeterna Zentaris Stock Is W
– Company obtains an exclusive license from The University of Sheffield, UK to intellectual property relating to parathyroid hormone (PTH) fusion polypeptides covering the field of human use which w
Aeterna Zentaris to Present at the H.C. Wainwright Global Life Sciences Conference
08:05am, Wednesday, 24'th Feb 2021
CHARLESTON, S.C., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeut
Aeterna Zentaris: Revisiting A Past Winner
05:26pm, Sunday, 21'st Feb 2021
Aeterna Zentaris was one of my previous winners, but a disappointing commercial launch for their flagship product, Macrilen, caused the share price to bleed for most of 2020. The company has been maki
Aeterna Zentaris Announces Closing of $29.7 Million Bought Deal Offering of Common Shares
01:25pm, Friday, 19'th Feb 2021
CHARLESTON, S.C., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and dev
